Gene expression analysis of a dedifferentiated liposarcoma - Differences between high and low grade areas. Analysis of two cases and literature review

Journal of Musculoskeletal Research

Volumn 9, Issue 1, 2005, Pages 9-20

  Hameed, Meera R ^a   Lin, Tao Zhen ^a   Coffman, Frederick ^a   Cohen, Marion C ^a   Fernandes, Helen ^a   Aviv, Hana ^a   Benevenia, Joseph ^a   Aisner, Seena C ^a   Cohen, Stanley ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Atypical lipomatous neoplasm well differentiated liposarcoma (WD); cDNA microarray; Dedifferentiated liposarcoma (DD); Reverse Transcriptase PCR (RT PCR)

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CASE REPORT; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MALE; MALIGNANT TRANSFORMATION; MEDICAL LITERATURE; METASTASIS POTENTIAL; NUCLEOTIDE SEQUENCE; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; TUMOR VOLUME; UNINDEXED SEQUENCE; UPREGULATION;

EID: 22844448893     PISSN: 02189577     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218957705001412     Document Type: Article

References (26)

1. Fletcher CDM, Soft tissue tumors, in Diagnostic Histopathology of Tumors, Churchill Livingstone, Edinburgh, pp. 1043-1096, 1995.
2. Evans L, Soule EH, Winkelman RK, Atypical lipoma, atypical intramuscular lipoma, and well-differentiated liposarcoma. A reappraisal of 30 cases formerly classified as well-differentiated liposarcoma, Cancer 43: 574-584, 1979.
3. Fletcher CDM, Akerman M, Dal Cin P, et al., Correlation between clinico-pathological features and karyotype in lipomatou s tumors: A report of 178 cases from chromosomes and morphology (CHAMP) collaborative study group, Am J Pathol 148: 623-630, 1996.
4. Rosai J, Akerman M, Dal Cin P, et al., Combined morphologic and phenotypic study of 59 atypical lipomatous tumors: Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of a CHAMP study group), Am J Surg Pathol 20: 1182-1189, 1996.
5. Meis-Kindblom JM, Sjogren H, Kindblom LG, Peydro-Mellquist A, Roijer E, Aman P, Stenman G, Cytogenetic and molecular genetic analysis of liposarcoma and its soft tissue simulators: Recognition of new variants and differential diagnosis, Virchows Arch 439: 141-151, 2001.
6. Weiss SW, Goldblum JR, Liposarcoma, in Enzinger FM, Weiss (eds.), Soft Tissue Tumors. 4th ed., Mosby Year Book, St.Louis, pp. 641-693, 2001.
7. Henricks WH, Chu YC, Goldblum JR, Weiss SW, Dedifferentiated liposarcoma: A clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation, Am J Surg Pathol 21: 271-281, 1997.
8. Weiss SW, Rao VK, Well-differentiated liposarcoma (atypical lipoma) of deep soft tissues of the extremities, retroperitoneum and miscellaneous sites: A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation", Am J Surg Pathol 16: 1051-1058, 1992.
9. Lucas DR, Nascimento AG, Sanjay KSS, Rock MG, Well-differentiated liposarcoma: The MAYO clinic experience with 58 cases, Am J Clin Pathol 102: 677-683, 1994.
10. McCormick D, Mentzel T, Beham A, Fletcher CDM, Dedifferentiated liposarcoma: Clinicopathologic analysis of 32 cases suggesting a better prognostic group among pleomorphic sarcomas, Am J Surg Pathol 18: 1213-1223, 1994.
11. Dal Cin P, Kools P, Sciot R, de Wever I, van Damme B, van de Ven W, van den Berghe H, Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic sub-group of adipose tissue tumors, Cancer Genet Cytogenet 68: 85-90, 1993.
12. Pedeutour F, Forus A, Coindre J-M, et al., Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors, Genes, Chromosomes, Cancer 24: 30-41, 1999.
13. Pedeutour F, Suijkerbuijk RF, Forus A, Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma, Genes, Chromosomes, Cancer 10: 85-94, 1994.
14. Wolf M, Aaltonen LA, Szymanska J, et al., Complexity of 12q13-22 amplicon in liposarcoma: Microsatellite repeat analysis, Genes, Chromosomes, Cancer 18: 66-700, 1997.
15. Pilotti S, Della Torre G, Lavarino C, Distinct mdm2/p53 expression patterns in liposarcoma subgroups: Implications for different pathogenetic mechanisms, J Pathol 181: 14-24, 1997.
16. Dei Tos AP, Doglioni C. Piccinin S. Co-ordinated expression and amplification of the MDM2. CDK4 and HMGI-C genes in atypical lipomatous tumors, J Pathol 190: 531-536, 2000.
17. Nishio J, Iwasaki H, Ishiguro M, et al., Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-I: Conventional and molecular cytogenetic characterization, Int J Oncol 22: 535-542, 2003.
18. Shimoji T, Kanda H, Kitagawa T, et al., Clinico-molecular study of dedifferentiation in well-differentiated liposarcoma, Biomed Biophy Res Comm 315: 1133-1140, 2004.
19. Fletcher CDM, Unni KK, Mertens F, World Health Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. IARC Press, Lyon, France, 2002.
20. Dei Tos AP, Doglioni C, Piccinin S, et al., Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma, J Pathol 181: 8-13, 1997.
21. Boltze C, Schneider-Stock R, Jager V, Roessner A, Distinction between lipoma and liposarcoma by MDM2 alterations: A case report and review of literature, Pathol Res Pract 197(8): 563-568, 2000.
22. Segal NH, Pavlidis P, Antonescu CR, et al., Classification and subtype prediction of adult soft tissue sarcoma by functional genomics, Am J Pathol 163: 691-700, 2003.
23. Hollak CE, van Weely S, van Oers MH, Aerts JM, Marked elevation of plasma chitotriosidase activity: A novel marker of Gaucher disease, J Clin Invest 93: 1288-1292, 1994.
24. Tjoelker LW, Gosting L, Frey S, et al., Structural and functional definition of the human chitinase chitin-binding domain. J Biol Chem: 275: 514-520, 2000.
25. Tanwar MK, Gilbert MR, Holland EC, Gene expression and microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma, Can Res 62: 4364-4368, 2002.
26. Johansen JS, Christensen IJ, Riisbro R, et al., High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival, Breast Cancer Res Treat 80(1): 15-21, 2003.